Paul Roos joined Polyganics in January 2015 with extensive experience and a proven track record in the international life sciences industry, having spent 10 years working in investment banking and three years as a CFO.
Most recently, Mr. Roos served as CFO of IRX Innovations, a leader in the field of reflective screen technology. Prior to IRX Innovations, Mr. Roos served as CFO of Synthon, a privately held specialty pharmaceutical company with over EUR 250 million in revenues. He began his career at the Corporate Finance Division of Kempen & Co, where he held positions of increasing responsibility, ultimately being named Executive Director in the Life Sciences/ Healthcare team. He spearheaded the development and roll-out of the European Life Sciences/ Healthcare franchise and advised on over 35 M&A and capital market transactions. These included the IPOs of Galapagos, Ablynx and Arseus and the public offers by QIAGEN for Ipsogen and by Alpinvest for Delft Instruments.
Mr. Roos obtained cum laude Master’s degrees in econometrics and business economics from the University of Amsterdam and participated in exchange programs at New York University and the Universitat Pompeu Fabra Barcelona.